Patents-Review.com
ClassID:

96510 ⎘

C07J7/0085 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Recent Application in this class:
#1
20260116912
2026-04-30

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #2
20260116911
2026-04-30

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #3
20250319106
2025-10-16

19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF

 #4
20240076310
2024-03-07

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #5
20240025942
2024-01-25

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #6
20230391816
2023-12-07

NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF

 #7
20230287037
2023-09-14

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

 #8
20230279044
2023-09-07

Neuroactive steroids, compositions, and uses thereof

 #9
20220110950
2022-04-14

19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof

 #10
20210403502
2021-12-30

Neuroactive steroids, compositions, and uses thereof

 #11
20210347812
2021-11-11

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #12
20210139531
2021-05-13

19-nor neuroactive steroids and methods of use thereof

 #13
20210094981
2021-04-01

Neuroactive steroids, compositions, and uses thereof

 #14
20210061850
2021-03-04

NEUROACTIVE STERIODS, COMPOSITIONS, AND USES THEREOF

 #15
20210061849
2021-03-04

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #16
20210061848
2021-03-04

Neuroactive steroids, compositions, and uses thereof

 #17
20210040141
2021-02-11

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

 #18
20200246459
2020-08-06

Compositions and methods for treating CNS disorders

 #19
20200223884
2020-07-16

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

 #20
20200165291
2020-05-28

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #21
20200155576
2020-05-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #22
20200048300
2020-02-13

19-NOR neuroactive steroids and methods of use thereof

 #23
20200024302
2020-01-23

Neuroactive steroids, compositions, and uses thereof

 #24
20200016178
2020-01-16

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #25
20190211054
2019-07-11

19-NOR NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF

 #26
20190169226
2019-06-06

Neuroactive steroids, compositions, and uses thereof

 #27
20190112331
2019-04-18

19-nor neuroactive steroids and methods of use thereof

 #28
20180311262
2018-11-01

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #29
20180179247
2018-06-28

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #30
20180141971
2018-05-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #31
20180051052
2018-02-22

19-nor neuroactive steroids and methods of use thereof

 #32
20180037602
2018-02-08

Neuroactive steroids, compositions, and uses thereof

 #33
20170342103
2017-11-30

3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof

 #34
20170319695
2017-11-09

Compositions and methods for treating CNS disorders

 #35
20170247406
2017-08-31

Neuroactive steroids, compositions, and uses thereof

 #36
20170246191
2017-08-31

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #37
20160108080
2016-04-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #38
20160009751
2016-01-14

C-19 HYDROXY PREGNENES

 #39
20150337006
2015-11-26

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

 #40
20140018312
2014-01-16

Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria

 #41
20130217903
2013-08-22

Process for preparing a crystalline form of halobetasol propionate

 #42
20120232042
2012-09-13

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases

 #43
20120184515
2012-07-19

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases

 #44
20100130760
2010-05-27

Process for preparing a crystalline form of halobetasol propionate

 #45
20100113408
2010-05-06

21-substituted progesterone derivatives as new antiprogestational agents

 #46
20090118248
2009-05-07

3-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof

 #47
20070167420
2007-07-19

Process for preparing a crystalline form of halobetasol propionate

 #48
20060276443
2006-12-07

21-substituted progesterone derivatives as new antiprogestational agents

 #49
20050176976
2005-08-11

GABAmodulating neurosteroids

 #50
20050143365
2005-06-30

Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents

 #51
20050143364
2005-06-30

21-substituted progesterone derivatives as new antiprogestational agents